Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06795945 · ClinicalTrials.gov registry record · NA

A Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Evaluate the Safety of a Bovine Thymus Nuclear Extract

A NA study, sponsored by Standard Process.

Completed
Registry status
NA
Development phase
80
Enrollment target

NCT06795945: Completed NA study, sponsored by Standard Process.

NCT06795945 is a NA study that has completed, run by Standard Process. The registered enrollment target is 80 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06795945, a NA study, has completed, sponsored by Standard Process.

COMPLETED
Registry status
NA
Development phase
80 participants
Enrollment target

Study Summary

The goal of this trial is to find out if Thymus Nuclear Extract is safe and well-tolerated in healthy men and women by testing three different dose levels and comparing the results to a placebo.

Primary Outcome

Heart rate (bpm)

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT TPG1
  • DIETARY_SUPPLEMENT TPG2
  • DIETARY_SUPPLEMENT TPG3

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2025-02-04
Est. Completion 2025-11-24
Phase NA
Standard Process

8 total trials

What the finished NCT06795945 record still lists

NCT06795945 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).

The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.

NCT06795945 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06795945 about?

NCT06795945 is a clinical study titled "A Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Evaluate the Safety of a Bovine Thymus Nuclear Extract". The goal of this trial is to find out if Thymus Nuclear Extract is safe and well-tolerated in healthy men and women by testing three different dose levels and comparing the results to a placebo.

What is the current status of trial NCT06795945?

This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2025-02-04. Estimated completion is 2025-11-24.

What interventions are being tested in trial NCT06795945?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), TPG1 (DIETARY_SUPPLEMENT), TPG2 (DIETARY_SUPPLEMENT), TPG3 (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT06795945?

This trial is sponsored by Standard Process, which has 8 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06795945's enrollment target sits among peer trials

80 994th of 2000 higher than 941 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

  • NCT01659203 · 80 participants · Phase 1

    Proton or Photon RT for Retroperitoneal Sarcomas

  • NCT01803451 · 80 participants · Early Phase 1

    Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

  • NCT01964859 · 80 participants · Phase 2

    Feasibility Study for Fibroblast Autologous Skin Grafts

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06795945, the US trial registry maintained by the National Library of Medicine. NCT06795945 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.